title: Phosphatidylethanolamine synthesized by three different pathways is supplied to peroxisomes of the yeast Saccharomyces cerevisiae.
abstract: In the yeast Saccharomyces cerevisiae three pathways lead to the formation of phosphatidylethanolamine (PE), namely decarboxylation of phosphatidylserine (PS) (i) by Psd1p in mitochondria, and (ii) by Psd2p in a Golgi/vacuolar compartment; and (iii) synthesis via CDP-ethanolamine pathway in the endoplasmic reticulum. To determine the contribution of these pathways to the supply of PE to peroxisomes, we subjected mutants bearing defects in the respective metabolic routes to biochemical and cell biological analysis. Despite these defects in PE formation mutants were able to grow on oleic acid indicating induction of peroxisome proliferation. Biochemical analysis revealed that PE formed through all three pathways was supplied to peroxisomes. These analyses also demonstrated that selective as well as equilibrium interorganelle flux of PE appear to be equally important for cellular homeostasis of this phospholipid. Electron microscopic inspection confirmed that defects in PE synthesis still allowed formation of peroxisomes, although these organelles from strains lacking PSD1 were significantly smaller than wild type. The fact that peroxisomes were always found in close vicinity to mitochondria, ER and lipid particles supported the view that membrane contact may play a role in lipid traffic between these organelles.
authors.affiliation: Institute of Biochemistry, Graz University of Technology, Petersgasse 12/2, A-8010 Graz, Austria.
authors.forename: Sabine
authors.initials: S
authors.lastname: Rosenberger
authors.forename: Melanie
authors.initials: M
authors.lastname: Connerth
authors.forename: Günther
authors.initials: G
authors.lastname: Zellnig
authors.forename: Günther
authors.initials: G
authors.lastname: Daum
mesh_terms: D015153:Blotting, Western; D053858:Metabolic Networks and Pathways / Q000187:drug effects; D009154:Mutation / Q000235:genetics; D019301:Oleic Acid / Q000494:pharmacology; D053141:Organelle Size / Q000187:drug effects; D020675:Peroxisomes / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D010714:Phosphatidylethanolamines / Q000096:biosynthesis*; D010743:Phospholipids / Q000032:analysis; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism* / Q000648:ultrastructure; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism
chemical_list: D010714:Phosphatidylethanolamines; D010743:Phospholipids; D019301:Oleic Acid; C483858:phosphatidylethanolamine